-
341
-
342
The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence
Published 2016-01-01“…Patients with chronic liver diseases (CLD) undergo a range of invasive procedures during their clinical lifetime. …”
Get full text
Article -
343
Lipid metabolism indicators provide tools for the diagnosis of non-alcoholic fatty liver disease: results of a nationwide survey
Published 2025-01-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
344
Association of high-sensitivity C-reactive protein with hepatic fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
Published 2025-02-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
345
Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated fatty liver disease…”
Get full text
Article -
346
-
347
Protective effects of small RNAs encapsulated in Artemisia Capillaris-derived exosomes against non-alcoholic fatty liver disease
Published 2025-01-01Subjects: “…nonalcoholic fatty liver disease…”
Get full text
Article -
348
Association between cardiovascular health and metabolic dysfunction-associated steatotic liver disease: a nationwide cross-sectional study
Published 2025-01-01“…Abstract Purpose Evidence concerning the effect of cardiovascular health (CVH) on the risk of metabolic dysfunctional-associated steatotic liver disease (MASLD) is scarce. This study aimed to investigate the association between CVH and MASLD. …”
Get full text
Article -
349
The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis
Published 2025-01-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
350
Predictive Value of the Triglyceride-Glucose Index for Metabolic-Associated Fatty Liver Disease in Individuals with Different Metabolic Obese Phenotypes
Published 2025-01-01“…The TyG index was calculated, and an abdominal ultrasound was performed to detect the presence of fatty liver disease. The aforementioned data were then subjected to statistical analysis.Results: The TyG index was significantly higher in the MAFLD group than in the non-MAFLD group (P < 0.001). …”
Get full text
Article -
351
Proportional mortality and years of potential life lost due to liver diseases among agricultural workers, Brazil, 2017 to 2022
Published 2025-01-01Subjects: “…Liver Diseases…”
Get full text
Article -
352
Establishing of a risk prediction model for metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
353
Association of Breastfeeding with Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis in mothers: A cross sectional survey
Published 2024-06-01“… Objective: To determine the association of Breastfeeding with Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis in mothers. …”
Get full text
Article -
354
LIVER DISEASE & SICKLE CELL DISEASE: AUTOIMMUNE HEPATITIS MORE THAN A COINCIDENCE; A SYSTEMATIC LITERATURE REVIEW.
Published 2023-10-01Subjects: Get full text
Article -
355
Global research trends in Chinese medicine for the treatment of non-alcoholic fatty liver disease (NAFLD): A bibliometric study
Published 2025-03-01Subjects: “…Non-alcoholic fatty liver disease…”
Get full text
Article -
356
Preventive role of Pastinaca sativa in mitigating metabolic dysfunction-associated steatotic liver disease via modulation of metabolic endotoxemia
Published 2025-02-01“…Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading global liver disorder. …”
Get full text
Article -
357
Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
Published 2025-12-01Subjects: “…Chronic liver disease…”
Get full text
Article -
358
Association of dietary quality and mortality in the non-alcoholic fatty liver disease and advanced fibrosis populations: NHANES 2005–2018
Published 2025-01-01“…BackgroundNonalcoholic fatty liver disease (NAFLD) has emerged as a significant global health concern, with advanced fibrosis increasing mortality risks. …”
Get full text
Article -
359
Exploring the mechanism of berberine treatment for atherosclerosis combined with non-alcoholic fatty liver disease based on bioinformatic and experimental study.
Published 2024-01-01“…Atherosclerosis (AS) and Non-alcoholic fatty liver disease (NAFLD) are chronic metabolic disorders with high prevalence and significant health impacts. …”
Get full text
Article -
360